UBS Group
PRNB

UBS Group’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

UBS Group’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-173
Closed -$10K – 8736
2020
Q2 		$10K Sell
173
-3,089
-95% -$191K ﹤0.01% 7053
2020
Q1 		$194K Sell
3,262
-10,537
-76% -$614K ﹤0.01% 4747
2019
Q4 		$756K Buy
13,799
+2,369
+21% +$88.5K ﹤0.01% 4474
2019
Q3 		$323K Buy
11,430
+9,788
+596% +$359K ﹤0.01% 4892
2019
Q2 		$55K Buy
+1,642
New +$51.3K ﹤0.01% 5845
2019
Q1 		– Sell
-2,113
Closed -$58K – 8429
2018
Q4 		$58K Buy
+2,113
New +$54.4K ﹤0.01% 5972

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

UBS Group's PRNB Position: Q3 2020 in Review

UBS Group sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 173 shares — an estimated $10K sold.

UBS Group first reported a position in PRNB in Q4 2018 and held it in 6 quarters. The position peaked at $756K in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • UBS Group reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • UBS Group sold 173 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $10K.
  • UBS Group first reported a position in Principia Biopharma Inc. Common Stock in Q4 2018 and held it in 6 quarters.
  • UBS Group's Principia Biopharma Inc. Common Stock position peaked at $756K in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on UBS Group's 13F filing for Q3 2020, filed 12 Nov 2020.